pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Peptide Therapeutic · news · pharmadog
← back to Peptide Therapeutic
News · Peptide Therapeutic
94
stories
Jul 21, 26
Samsung Biologics targets $1.8B PolyPeptide buyout to expand in obesity
biospace
Jul 21, 26
Notes from a peptide meetup
endpoints
Jul 21, 26
Novartis drops phase 2 radioligand therapy, but CEO’s commitment to modality ‘unchanged’
fiercebiotech
Jul 20, 26
Samsung Bio to step into peptides in $1.8B buy for PolyPeptide
endpoints
Jul 20, 26
Bristol Myers to build ‘powerful’ AI factory; Samsung Biologics bids for peptide maker
biopharma dive
Jul 20, 26
Type 1 diabetes pipeline making ‘remarkable progress’ toward insulin independence
biospace
Jul 17, 26
Experts: Ending adequate provision would shut down prescription drug ads
raps
Jul 17, 26
Industry wants more clarity on NGS for assessing gene therapy safety
raps
Jul 17, 26
This Week at FDA: FDA staff raise concerns about peptide conflicts, top Democrat wants DOGE investigation, and more
raps
Jul 16, 26
Merck wins first approval of a PCSK9 cholesterol pill
biopharma dive
Jul 16, 26
Merck dives into cholesterol with first FDA approval for oral PCSK9 inhibitor
biospace
Jul 16, 26
Opinion: The growing fang-to-pharmacy pipeline
stat
Jul 14, 26
Fresh off buyout, Akero execs reunite to advance long-acting psoriasis pill
biopharma dive
Jul 8, 26
Opinion: STAT+: What’s the right role for AI in dementia care?
stat
Jul 8, 26
Opinion: The AI licensure debate is missing the point of licensure
stat
Jul 7, 26
Opinion: What if this Ebola outbreak can’t be stopped?
stat
Jul 6, 26
Opinion: The smart way to regulate the peptide boom
stat
Jul 6, 26
Opinion: Stopping doctors from ordering unnecessary diagnostic tests requires a structural fix
stat
Jun 30, 26
STAT+: Pharmalittle: We’re reading about Chinese trial sites being probed, RFK Jr. and peptides, and more
stat
Jun 30, 26
Half of states sue over Medicaid work requirements
stat
Jun 29, 26
STAT+: Longevity, wellness physicians named to panel advising FDA on peptides
stat
Jun 29, 26
10 clinical trials to watch in the second half of 2026
biopharma dive
Jun 15, 26
FDA Approves New Indication for Tzield (teplizumab) for Certain Pediatric Patients with Recently Diagnosed Stage 3 Type 1 Diabetes
fda press
Jun 11, 26
STAT+: An obesity drug deep-dive, and peptides move mainstream
stat
Jun 10, 26
Parabilis sets a record with a $670M biotech IPO
biopharma dive
Jun 4, 26
Parabilis Medicines charts $413M IPO to back peptide pipeline
endpoints
Jun 1, 26
STAT+: A turning point for pancreatic cancer patients
stat
Jun 1, 26
CDC says containing the spread of Ebola is top priority
stat
Jun 1, 26
The hidden history of BPC-157, a favorite MAHA peptide
stat
May 18, 26
Høeg fired in latest FDA shakeup; 20 people die after taking Amgen drug
biopharma dive
← prev
page 3 of 4
next →
